Home › Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs
 

Keywords :   


Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs

2013-10-02 05:59:57| drugdiscoveryonline News Articles

Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, recently announced that it is partnering with the Critical Path Institute (“C-Path”) to develop a physiologically-based pharmacokinetic (PBPK) model of the human lung

Tags: test model partners develop

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »